Medications

Taltz

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TALTZ® This medicine is subject to additional monitoring. This will allow quick identificationof new safety information. You can help by reporting any side effects you may get.You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . Prefilled Autoinjector and Prefilled […]

Medications

Blooms the Chemist Celecoxib

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BLOOMS THE CHEMIST CELECOXIB CAPSULES Celecoxib Consumer Medicine Information   What is in this leaflet Read this leaflet carefully before taking your medicine. This leaflet answers some common questions about celecoxib. It does not contain all the available information. It does not […]

Medications

Genotropin MiniQuick

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GENOTROPIN MINIQUICK® somatropin (rbe), recombinant human growth hormone Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions that you may have about GENOTROPIN MiniQuick. It does not contain all the available information. It does not […]

Health News

New arthritis pill that can end the hell of stiff joints

New £10-000-a-year arthritis pill that can end the hell of stiff joints could bring relief to more than 400,000 Britons Some 400,000 Britons suffer from rheumatoid arthritis and are in great pain Many young people suffering with the condition can be left using wheelchairs  Current treatments are only able to soothe pain or dampen the […]

Medications

Simponi Aria (golimumab) Approved by the FDA for Active Polyarticular Juvenile Idiopathic Arthritis and Extension of Its Active Psoriatic Arthritis Indication in Patients 2 Years of Age and Older

HORSHAM, PA, September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Simponi Aria (golimumab) for patients 2 years of age and older for the treatment of active pJIA and has extended the PsA indication for this same patient population. “This […]

Health News

Arthritis drug may improve respiratory function in some patients with severe covid-19

A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients with severe coronavirus disease 2019 (COVID-19). The eight patients also had a condition called secondary hemophagocytic lymphohistiocytosis (sHLH), which is characterized by overactivation of the immune system and organ failure. One patient, […]

Health News

How a plant-based diet can ease rheumatoid arthritis

Switching to a plant-based diet can alleviate the pain caused by rheumatoid arthritis, a new study shows. Rheumatoid arthritis is a type of inflammatory polyarthritis, characterized by inflammation in more than four joints. Rheumatoid arthritis occurs when your immune system attacks the synovium—the lining of the membranes that surround your joints, the Mayo Clinic states […]

Health News

Psoriasis therapy linked to reduced coronary inflammation in patients with skin condition: Novel imaging biomarker could track interventions on coronary artery disease

Researchers have found that anti-inflammatory biologic therapies used to treat moderate to severe psoriasis can significantly reduce coronary inflammation in patients with the chronic skin condition. Scientists said the findings are particularly notable because of the use of a novel imaging biomarker, the perivascular fat attenuation index (FAI), that was able to measure the effect […]